STEAP3 and colorectal carcinoma: To validate the effect of STEAP3-AS1, activation of the Wnt signaling pathway was firstly examined by nuclear translocation of β-catenin in CRC cells with STEAP3-AS1 manipulation (the GSK3β inhibitor CHIR-99021 was used as a positive control).